FY2025-Annual-Report

28 Meeting Challenges Head On The LSIC members are pharmaceutical and life sciences companies and other related organizations. They meet regularly with service providers and staff from DMAHS and DMHAS to share and gain valuable information that contributes to their individual and collaborative initiatives in increasing access to all healthcare treatment and services. Panel Discussion: Access to Medications MODERATOR Debbie Hart President and CEO, BioNJ PRESENTERS New Jersey Assemblyman Roy Freiman (D-16th District) Alyssa Lovill, MA, QMHP Executive Director, Epilepsy Foundation New Jersey Stephen M. Scheinthal, DO, FACN, DFAPA Chief of Psychiatry, Jefferson Health New Jersey Brian Oliveira, PharmD Executive Director, Garden State Pharmacy Owners Horizon Blue Cross Blue Shield of New Jersey’s Offerings to Ensure Whole-Person Care Nickolas Carros, DSW, LCSW Senior Director, Behavioral Health Clinical Services Atlantic Health System’s Partnership with FeelBetter’s Precision Population Health Platform Lori Ann Rizzuto, LCSW Executive Director Members: Alkermes, Inc. Biogen/Sage Therapeutics BioNJ H ealthCare Institute of New Jersey J anssen Pharmaceuticals/Johnson & Johnson Health Care System The Changing Federal Environment and its Impact on Behavioral Health and the Life Sciences and Pharmaceutical Industries and Individuals Served Lizzy Fox Senior Director of Federal Government Relations, Biotechnology Innovation Organization D evelopments in Treating Alzheimer’s Disease Howard Fillit, MD Co-Founder and Chief Science Officer, Alzheimer Drug Discovery Foundation B ergen New Bridge Medical Center’s Innovative Programs for Treating Complex Behavioral Health Conditions Darian Eletto, MEd, LPC, LCADC, NCC, ACS Chief Clinical Officer of Behavioral Health Services Nearly every meeting features an informative presentation. Examples from FY2025 are: Life Sciences and Innovation Council (LSIC) CO-CHAIRS: Leslie Stein Lloyd, JD, CAE, IOM Healthcare Policy and Advocacy Director Johnson & Johnson Health Care Systems, Inc Mary Kay Roberts Partner Riker Danzig Scherer Hyland Perretti LLP Neurocrine Biosciences Pfizer, Inc. Pharma-Care, Inc. S umimoto Pharma America, Inc.